Multiplying the total number of DALYs by the VSLY in 2010 (€94,794) provides an estimate of the euro value of the burden of disease from vision loss in the ROI. A constant VSLY value was applied to the years 2015 and 2020.
Estimates of the monetary equivalents of the DALY burdens for 2010, 2015 and 2020 are presented in Table 5.4. Burden of disease was valued at nearly €1.8 billion in 2010, and is projected to rise to over €2.2 billion by 2020.
Table 5.4: DALY burden (€’000) from VI and blindness in the ROI
| 2010 | 2015 | 2020 | |
|---|---|---|---|
| Estimated DALYs | 18,537 | 20,804 | 23,465 |
| VSLY applied | €94,794 | €94,794 | €94,794 |
| Disease burden monetary value (€‘000) | €1,757,158 | €1,972,114 | €2,224,365 |
Source: Deloitte Access Economics calculations using Stouthard et al (1997), prevalence estimates from Chapter 2, ABS (2010), CSO (2008; 2009; 2010g), Department of Finance (2010), McCarty et al (2001), Mason et al (2009), UK National Statistics (2010) and ECB (2011).